TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded without competitionTransparency notice
Published 17 Jun 2026, 12:07 BST

Official UK procurement notice

Macroeconomic Study Phase II

Official notice

Authority: Cell & Gene Therapy Catapult (Public body)

Direct awardSME suitableVCSE suitable
Sectors: Research & Development (R&D) (73) Delivery: North East (UKC)North West (UKD)Yorkshire & Humber (UKE)
+6 moreEast Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)South West (UKK)
Awarded value£293,244published award · inc. VAT
Award in standstill Not publishedno call for competition
Award (standstill) to OHE Consulting Ltd

What is being bought

Published requirement description

To carry out Phase II of the

macroeconomic evaluation of the potential of cell and gene therapies.

The lotProcurement structure

single lot · no lot value published
Lot #1AwardedSMEVCSE
Delivery: North East, North West, Yorkshire & Humber, East Midlands, West Midlands, East of England, London, South East, South WestEligibility: SME eligibleVCSE eligible
73000000 Research and development services and related consultancy services

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
17 Jun 2026, 12:07 BST
Last source update
17 Jun 2026, 12:07 BST
FTS notice number
2026/S 000-057060
Latest notice
Transparency notice (UK5)
Delivery area
North East (UKC)North West (UKD)Yorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)
+1 moreSouth West (UKK)
Official registry OCID
ocds-h6vhtk-06b6dd Find a Tender
Why no open competition
Urgency
Published justification

This is a continuation of a project already carried out by OHE Consulting Ltd for CGT

Catapult. OHE will be carrying out the second phase of the macroeconomic evaluation of

the potential of cell and gene therapies. This second phase will evaluate the wider

benefits and costs.

OHE Consulting Ltd were given a direct award to carry out the first phase of the study due

to their specific macroeconomic skills, as well as a thorough understanding of the ATMP

space. It would not be appropriate to put this project continuation out to tender given the

bespoke and niche nature of the work.

Notice history

2 events · 1 release on Find a Tender · since 17 Jun 2026
  1. Transparency notice published
    17 Jun 2026, 12:07 BST
    UK5
  2. Contract signature expected
    30 Jun 2026, 23:59 BST
    scheduled

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1some still in standstill
Awarded value (inc. VAT) £293,2441 award inc. VAT; no net value published
Awarded toValueDateStatus
OHE Consulting LtdSME31 Jul 2026 – 30 Jul 2027£293,244 inc. VAT—Standstill

Contracting authority & participating public bodies

CELL THERAPY CATAPULT LIMITED

Contracting authorityPublic authority - sub-central government GB-COH: 07964711 · GB-PPON: PNLN-8116-PBCH 12th Floor Tower Wing B, London, London, SE1 9RTContact email

Bidders & participating suppliers

1 commercial party on the notice
  • OHE Consulting LimitedAwarded supplierGB-COH: 09853113 Goldings House Hay's Galleria, London, London, SE1 2HBContact email

Official documents & specifications (1)

Official links; attachments are not copied

Notices published for this procedure

  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender